President Donald Trump announced that he revoked Joe Biden’s security clearance and ended his daily intelligence briefings.
Trump stated there is no need for Biden to continue receiving access to classified information and that his administration cited Biden’s ‘poor memory”.
Trump, 78, argued that the former president set the precedent when he barred him from receiving access to the same briefings four years ago, citing Trump’s “erratic behavior.”“There is no need for Joe Biden to continue receiving access to classified information,” Trump wrote in a Truth Social Post.“Therefore, we are immediately revoking Joe Biden’s Security Clearances, and stopping his daily Intelligence Briefings,” the president continued.“He set this precedent in 2021, when he instructed the Intelligence Community (IC) to stop the 45th President of the United States (ME!) from accessing details on National Security, a courtesy provided to former Presidents.”Ex-presidents and other former senior officials customarily retain access to classified information.
And as Biden’s ‘poor memory” and potential Alzheimer’s condition had been a worry for many Americans until last month’s inauguration of Trump, it is interesting to note that recent research has revealed a concerning connection between microplastics and Alzheimer’s disease.
Studies have found that people diagnosed with dementia, including Alzheimer’s, have up to 10 times more microplastics present in their brains than those without the condition.
Published in the Nature Medicine journal, the study by researchers from the University of New Mexico and the University of Oklahoma found that microplastic levels in human brains have increased by 50% over the past eight years. Dementia patients had up to 10 times more plastic in their brains than others according to the findings.“This study joins a growing body of research on the potential harm of plastic particle accumulation in the body,” said Dr. Nirit Lev, head of Meir Medical Center’s neurology department.“We used to focus on risk factors like medical history, physical activity, smoking and weight. Now we have a nearly invisible new factor — plastic particles — that we still struggle to measure and understand,” she explained.The study examined brain, liver and kidney samples, finding the highest plastic concentrations in the brain. In 2016, average brain plastic levels were 3,345 micrograms per gram; by 2024, they had risen 50% to 4,917 micrograms per gram.Dementia patients had 7 to 30 times more plastic in their brains than in other organs.
Of course, correlation is not causation. But given how plastic and phony Biden has been throughout his disgraceful career, it certainly is an intriguing explanation…at least in his case.
I would also like to point out that skepticism is warranted. Microplastics have become a target in recent years of eco-activists and those who despise the fossil fuel industry. As the discoveries related to USAID have revealed, a serious look at the funding that inspired this research must be had to ensure the researchers are doing an honest investigation and not one driven by supporting the latest narrative.
Fraud has been associated with research into Alzheimer’s disease. A major scandal in Alzheimer’s research emerged in 2022 when evidence of potential fraud was uncovered in several influential studies.
The controversy centered around a 2006 paper published in Nature, which identified a specific assembly of proteins called Aβ*56 as a promising target for Alzheimer’s treatment.
A publication in Science has uncovered a possible case of fraud in a major line of Alzheimer’s research. The alarm was raised by Matthew Schrag, a neuroscientist and neuroscientist at Vanderbilt University, and the journal itself continued the analysis. Specifically, they identified that there were all sorts of image manipulations in at least ten articles on the so-called Aβ*56 peptide. All of them included the byline of neuroscientist Sylvain Lesné.Aβ*56 is a form in which the beta-amyloid protein, the substance that is found forming plaques in the brains of Alzheimer’s patients and which, according to the dominant theory of the last decades, is responsible for initiating the disease, can occur.One of these ten papers is one of the most cited in the history of Alzheimer’s research. Published in Nature in 2006, it claimed that injecting the Aβ*56 form into healthy rats caused them to develop memory loss. It was the first time that a substance, theoretically present in the brains of people with Alzheimer’s disease, had been shown to directly cause these symptoms. It was an endorsement of the amyloid hypothesis.
Hopefully, a sweep-and-clean of grant funding and controls and better oversight of what type of research receives funding will make all scientific findings more trustworthy.
And, of course, the new study will likely be used as another excuse to attack Trump.
CLICK HERE FOR FULL VERSION OF THIS STORY